Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

HIV Infections × Nurse Clinicians × Lymphoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Melanoma 1 Lymphoma, Large B-Cell, Diffuse 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Hematologic Neoplasms 1 HIV Infections 1

Interventions

Cyclophosphamide 12 Vincristine 9 Doxorubicin 9 Etoposide 8 Rituximab 6 Cytarabine 6 Prednisone 5 Dexamethasone 5 Zidovudine 4 Peripheral Blood Stem Cell Transplantation 4 Methotrexate 4 Leucovorin 4 Bleomycin 4 Filgrastim 3 Carmustine 3 sargramostim 2 fludarabine phosphate 2 fludarabine 2 Whole-Body Irradiation 2 Polymerase Chain Reaction 2 Melphalan 2 Antiretroviral Therapy, Highly Active 2 Allopurinol 2 prednylidene 1 pembrolizumab 1 liposomal doxorubicin 1 ibrutinib 1 efavirenz 1 deltacortene 1 carmustine, poliferprosan 20 drug combination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00466258 2009-11-25

LINFOTARGAM

PETHEMA Foundation

Phase 4 Completed

HIV Infections, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡